Skip to main content

Generics

  • Court upholds Lilly's patent for Cymbalta

    INDIANAPOLIS — Drug maker Eli Lilly will get at least two more years of patent exclusivity on a drug used to treat depression, anxiety and pain resulting from diabetic neuropathy and fibromyalgia, thanks to a court order issued Wednesday.

    The U.S. District Court for the Southern District of Indiana ruled to forbid Wockhardt and other generic drug companies from selling generic versions of Cymbalta (duloxetine hydrochloride) until patent protection expires, which is expected to occur in June 2013.

  • PCMA: Mail-service pharmacies drive generic utilization

    WASHINGTON — An organization representing the nation's pharmacy benefit managers said that mail-service pharmacies are increasing the use of generic medications.

    The Pharmaceutical Care Management Association issued a statement on Tuesday claiming that mail-service pharmacies leverage generic opportunities for savings, adding that there is no marked difference in the generic dispensing rate between mail-service pharmacy and retail pharmacy.

  • Taro resolves FDA warning letter

    HAWTHORNE, N.Y. — Taro said that the Food and Drug Administration has declared the drug maker's manufacturing facility in Canada as having acceptable regulatory status.

    The drug maker said it diligently worked to resolve issues noted in an FDA warning letter dated Feb. 5, 2009. The regulatory agency reinspected the manufacturing facility last February.

  • Hospira reports Q1

    LAKE FOREST, Ill. — Hospira had net sales of $1 billion during first quarter 2011, the generic drug maker said Tuesday.

    Sales for the quarter, which ended March 31, declined by 0.5%, compared with first quarter 2010, while profits were $149.9 million, a 5.8% increase over last year.

  • H-E-B adding clinics, new Rx services

    “After all, we’re from around here, too.” That message, delivered to millions of Texas consumers via the pharmacy page on H-E-B’s heavily scanned website, lies at the heart of the San Antonio-based supermarket chain’s seemingly unshakeable grip on both customers and patients in the Lone Star State. The H.E. Butt Grocery Co. maintains high marks for customer loyalty, innovative patient care services, a quality shopping experience and plenty of healthy choices in its food aisles.


  • Winn-Dixie renews ‘fresh & local’ appeal

    
If sports columnists covered Winn-Dixie, their story line would read something like this: The Jacksonville, Fla.-based retailer has climbed back into the ring as a slimmed-down and much-improved fighter competing in a lighter weight class. 


  • Meijer disputes belief that nothing is free

    The Midwest is known for flat landscapes and fertile farm fields stretching to the horizon, but it also is home to one of the country’s oldest and most successful mass merchandise chains — one with a long history of strong emphasis on pharmacy programs.


    Where a growing number of chains have adopted generic discount programs, Meijer has taken to giving many drugs away for free. The list of medications that customers can obtain at no charge now includes metformin for Type 2 diabetes, prenatal vitamins and most antibiotics.


  • Pozen, AstraZeneca file suit against Dr. Reddy's over generic Vimovo

    CHAPEL HILL, N.C. — A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.

X
This ad will auto-close in 10 seconds